NCT02493179View on ClinicalTrials.gov

Efficacy Evaluation of the (Serodase 5 mg Tablet) in the Treatment of Inflammation After Third Molar Surgery

PHASE4UnknownINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

February 29, 2016

Conditions
TrismusSwellingInflammation
Interventions
DRUG

Serodase 5 mg

Serodase 5mg two tablets three times per day

DRUG

Placebo

Placebo two tablets three times per day

Sponsors
All Listed Sponsors
lead

Hayat Pharmaceutical Co. PLC

INDUSTRY